Skip to main content
Erschienen in: World Journal of Urology 7/2016

28.10.2015 | Original Article

Low yield of surveillance imaging after surgery for T1 kidney cancer

verfasst von: Michael A. Feuerstein, John E. Musser, Matthew Kent, Michael Chevinsky, Eugene K. Cha, Simon Kimm, William M. Hilton, Daniel D. Sjoberg, Timothy F. Donahue, Hebert A. Vargas, Jonathan A. Coleman, Paul Russo

Erschienen in: World Journal of Urology | Ausgabe 7/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To examine the mode of relapse detection and subsequent treatment after partial or radical nephrectomy in patients with low-risk (pT1, N0, Nx) kidney cancer.

Methods

Retrospective study on 1404 patients treated with partial or radical nephrectomy for low-risk kidney cancer from the years 2000–2012. Scans for chest imaging (X-ray or CT) and abdominal imaging (CT, MRI, or ultrasound) are tabulated. For those patients with relapse, the site, mode of detection, and symptoms were recorded.

Results

Twenty-one patients relapsed with a median follow-up of 4.1 years for patients who did not relapse. In 17 (81 %) patients, relapse was detected by imaging alone, while 4 (19 %) patients presented with symptoms. Of the patients who relapsed by imaging, 13 (76 %) were treated immediately, while 4 (24 %) continued observation. During the first 3 years of follow-up, 5762 imaging studies were performed to detect 8 relapses, with 6 patients receiving immediate treatment. The median number of imaging studies per patient per year for the first 3 years was 1.7 (interquartile range 1.0, 2.3) including 30 % CT, 3 % MRI, 36 % X-ray, and 31 % ultrasounds.

Conclusion

We found a low yield of surveillance imaging in the first 3 years for pT1 kidney cancer. Nearly 1000 imaging studies were performed to detect one relapse that required treatment. Further studies are needed to evaluate the clinical impact of imaging surveillance according to recent guidelines.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Campbell SC, Novick AC, Belldegrun A, Blute ML, Chow GK, Derweesh IH et al (2009) Guideline for management of the clinical T1 renal mass. J Urol 182:1271–1279CrossRefPubMed Campbell SC, Novick AC, Belldegrun A, Blute ML, Chow GK, Derweesh IH et al (2009) Guideline for management of the clinical T1 renal mass. J Urol 182:1271–1279CrossRefPubMed
3.
Zurück zum Zitat Donat SM, Diaz M, Bishoff JT, Coleman JA, Dahm P, Derweesh IH et al (2013) Follow-up for clinically localized renal neoplasms: AUA guideline. J Urol 190(2):407–416CrossRef Donat SM, Diaz M, Bishoff JT, Coleman JA, Dahm P, Derweesh IH et al (2013) Follow-up for clinically localized renal neoplasms: AUA guideline. J Urol 190(2):407–416CrossRef
4.
Zurück zum Zitat Hafez KS, Novick AC, Campbell SC (1997) Patterns of tumor recurrence and guidelines for followup after nephron sparing surgery for sporadic renal cell carcinoma. J Urol 157:2067–2070CrossRefPubMed Hafez KS, Novick AC, Campbell SC (1997) Patterns of tumor recurrence and guidelines for followup after nephron sparing surgery for sporadic renal cell carcinoma. J Urol 157:2067–2070CrossRefPubMed
5.
Zurück zum Zitat Levy DA, Slaton JW, Swanson DA, Dinney CP (1998) Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma. J Urol 159:1163–1167CrossRefPubMed Levy DA, Slaton JW, Swanson DA, Dinney CP (1998) Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma. J Urol 159:1163–1167CrossRefPubMed
6.
Zurück zum Zitat Ljungberg B, Alamdari FI, Rasmuson T, Roos G (1999) Follow-up guidelines for nonmetastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomy. BJU Int 84:405–411CrossRefPubMed Ljungberg B, Alamdari FI, Rasmuson T, Roos G (1999) Follow-up guidelines for nonmetastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomy. BJU Int 84:405–411CrossRefPubMed
7.
Zurück zum Zitat Sandock DS, Seftel AD, Resnick MI (1995) A new protocol for the followup of renal cell carcinoma based on pathological stage. J Urol 154:28–31CrossRefPubMed Sandock DS, Seftel AD, Resnick MI (1995) A new protocol for the followup of renal cell carcinoma based on pathological stage. J Urol 154:28–31CrossRefPubMed
8.
Zurück zum Zitat Stephenson AJ, Chetner MP, Rourke K, Gleave ME, Signaevsky M, Palmer B et al (2004) Guidelines for the surveillance of localized renal cell carcinoma based on the patterns of relapse after nephrectomy. J Urol 172:58–62CrossRefPubMed Stephenson AJ, Chetner MP, Rourke K, Gleave ME, Signaevsky M, Palmer B et al (2004) Guidelines for the surveillance of localized renal cell carcinoma based on the patterns of relapse after nephrectomy. J Urol 172:58–62CrossRefPubMed
9.
Zurück zum Zitat Lam JS, Shvarts O, Leppert JT, Pantuck AJ, Figlin RA, Belldegrun AS (2005) Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system. J Urol 174:466–472 (discussion 72; quiz 801) CrossRefPubMed Lam JS, Shvarts O, Leppert JT, Pantuck AJ, Figlin RA, Belldegrun AS (2005) Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system. J Urol 174:466–472 (discussion 72; quiz 801) CrossRefPubMed
10.
Zurück zum Zitat Feuerstein MA, Atoria CL, Pinheiro LC, Huang WC, Russo P, Elkin EB (2014) Patterns of surveillance imaging after nephrectomy in the medicare population. BJU Int. doi:10.1111/bju.12980 Feuerstein MA, Atoria CL, Pinheiro LC, Huang WC, Russo P, Elkin EB (2014) Patterns of surveillance imaging after nephrectomy in the medicare population. BJU Int. doi:10.​1111/​bju.​12980
11.
Zurück zum Zitat Kowalczyk KJ, Harbin AC, Choueiri TK, Hevelone ND, Lipsitz SR, Trinh QD et al (2013) Use of surveillance imaging following treatment of small renal masses. J Urol 190:1680–1685CrossRefPubMed Kowalczyk KJ, Harbin AC, Choueiri TK, Hevelone ND, Lipsitz SR, Trinh QD et al (2013) Use of surveillance imaging following treatment of small renal masses. J Urol 190:1680–1685CrossRefPubMed
12.
Zurück zum Zitat Stewart SB, Thompson RH, Psutka SP, Cheville JC, Lohse CM, Boorjian SA et al (2014) Evaluation of the national comprehensive cancer network and american urological association renal cell carcinoma surveillance guidelines. J Clin Oncol 32:4059–4065CrossRefPubMedPubMedCentral Stewart SB, Thompson RH, Psutka SP, Cheville JC, Lohse CM, Boorjian SA et al (2014) Evaluation of the national comprehensive cancer network and american urological association renal cell carcinoma surveillance guidelines. J Clin Oncol 32:4059–4065CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Eggener SE, Yossepowitch O, Pettus JA, Snyder ME, Motzer RJ, Russo P (2006) Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence. J Clin Oncol 24:3101–3106CrossRefPubMed Eggener SE, Yossepowitch O, Pettus JA, Snyder ME, Motzer RJ, Russo P (2006) Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence. J Clin Oncol 24:3101–3106CrossRefPubMed
15.
Zurück zum Zitat Preston DL, Ron E, Tokuoka S, Funamoto S, Nishi N, Soda M et al (2007) Solid cancer incidence in atomic bomb survivors: 1958–1998. Radiat Res 168:1–64CrossRefPubMed Preston DL, Ron E, Tokuoka S, Funamoto S, Nishi N, Soda M et al (2007) Solid cancer incidence in atomic bomb survivors: 1958–1998. Radiat Res 168:1–64CrossRefPubMed
16.
Zurück zum Zitat Lin YK, Gettle L, Raman JD (2013) Significant variability in 10-year cumulative radiation exposure incurred on different surveillance regimens after surgery for pT1 renal cancers: yet another reason to standardize protocols? BJU Int 111(6):891–896CrossRefPubMed Lin YK, Gettle L, Raman JD (2013) Significant variability in 10-year cumulative radiation exposure incurred on different surveillance regimens after surgery for pT1 renal cancers: yet another reason to standardize protocols? BJU Int 111(6):891–896CrossRefPubMed
17.
Zurück zum Zitat Smith-Bindman R, Lipson J, Marcus R, Kim KP, Mahesh M, Gould R et al (2009) Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med 169:2078–2086CrossRefPubMedPubMedCentral Smith-Bindman R, Lipson J, Marcus R, Kim KP, Mahesh M, Gould R et al (2009) Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med 169:2078–2086CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Lee DW, Levy F (2012) The sharp slowdown in growth of medical imaging: an early analysis suggests combination of policies was the cause. Health Aff (Millwood) 31:1876–1884CrossRef Lee DW, Levy F (2012) The sharp slowdown in growth of medical imaging: an early analysis suggests combination of policies was the cause. Health Aff (Millwood) 31:1876–1884CrossRef
19.
Zurück zum Zitat Dinan MA, Curtis LH, Hammill BG, Patz EF Jr, Abernethy AP, Shea AM et al (2010) Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999–2006. JAMA 303:1625–1631CrossRefPubMed Dinan MA, Curtis LH, Hammill BG, Patz EF Jr, Abernethy AP, Shea AM et al (2010) Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999–2006. JAMA 303:1625–1631CrossRefPubMed
20.
Zurück zum Zitat Hillman BJ, Goldsmith J (2010) Imaging: the self-referral boom and the ongoing search for effective policies to contain it. Health Aff (Millwood) 29:2231–2236CrossRef Hillman BJ, Goldsmith J (2010) Imaging: the self-referral boom and the ongoing search for effective policies to contain it. Health Aff (Millwood) 29:2231–2236CrossRef
21.
Zurück zum Zitat Loprinzi CL, Hayes D, Smith T (2003) Doc, shouldn’t we be getting some tests? J Clin Oncol 21:108s–111sCrossRefPubMed Loprinzi CL, Hayes D, Smith T (2003) Doc, shouldn’t we be getting some tests? J Clin Oncol 21:108s–111sCrossRefPubMed
Metadaten
Titel
Low yield of surveillance imaging after surgery for T1 kidney cancer
verfasst von
Michael A. Feuerstein
John E. Musser
Matthew Kent
Michael Chevinsky
Eugene K. Cha
Simon Kimm
William M. Hilton
Daniel D. Sjoberg
Timothy F. Donahue
Hebert A. Vargas
Jonathan A. Coleman
Paul Russo
Publikationsdatum
28.10.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 7/2016
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-015-1719-9

Weitere Artikel der Ausgabe 7/2016

World Journal of Urology 7/2016 Zur Ausgabe

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.